BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 22, 2026
See today's BioWorld Asia
Home
» Biotie Gets $38M in Placing with Lundbeck, Institutions
To read the full story,
subscribe
or
sign in
.
Biotie Gets $38M in Placing with Lundbeck, Institutions
Sep. 12, 2012
By
Cormac Sheridan
With two key value inflection points approaching, Biotie Therapies Oy did some advance corporate housekeeping by adding €30 million (US$38.3 million) to its coffers, to strengthen its position for any upcoming licensing negotiations.
BioWorld Asia